Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Clinical Trial of Proton Craniospinal Irradiation Versus Involved-Field Radiotherapy for Patients With Breast Cancer or Non-Small Cell Lung Cancer Leptomeningeal Metastasis (Radiate-LM)

NCT06500481 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT06500481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06500481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Clinical Trial of Proton Craniospinal Irradiation Versus Involved-Field Radiotherapy for Patients With Breast Cancer or Non-Small Cell Lung Cancer Leptomeningeal Metastasis (Radiate-LM)
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Recruiting
Start date
March 4, 2025
Completion date
July 31, 2033
Enrollment
115 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, metastatic breast carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant neoplasm in the leptomeninges, stage iv lung cancer ajcc v8